This Acquirers Multiple Stock Is Undervalued, According to Burry, Greenblatt, And Dalio

Part of the weekly research here at The Acquirer’s Multiple features some of the top picks from our Stock Screeners and some top investors who are holding these same picks in their portfolios. Investors such as Warren Buffett, Joel Greenblatt, Carl Icahn, Jim Simons, Prem Watsa, Jeremy Grantham, Seth Klarman, Ray Dalio, and Howard Marks. The top investor data is provided from their latest 13F’s. This week we’ll take a look at:

CVS Health Corp (CVS)

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company’s recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.

A quick look at the price chart below shows us that the stock is down 28.68% in the past twelve months. We currently have the stock trading on an Acquirer’s Multiple of 10.00 which means that it remains undervalued.

CVS data by YCharts

(Shares)

Cliff Asness – 4,955,000

Ray Dalio – 2,686,418

Israel Englander – 2,092,488

Ken Griffin – 889,666

Bernard Horn – 633,800

Paul Tudor Jones – 380,110

Tom Gayner – 332,000

Mario Gabelli – 217,946

Joel Greenblatt – 173,626

Michael Burry – 100,000